Alcohol, Cannabis, and Driving Substudy III
common.study.values.description
“Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III”
The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Active Dronabinol
10 mg capsule of Dronabinol will be administered orally.
Drug - Placebo
Control: no alcohol, administered for ~80 minutes.
Drug - Placebo
Control: Placebo pill (no active cannabinoids) administered orally.
Drug - Active Ethanol
Target BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III
common.study.values.clinical-trial-id
NCT02710331
participant.views.study.view.id
ZdPJ6a
